{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T21:06:34Z","timestamp":1763499994698,"version":"3.37.3"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T00:00:00Z","timestamp":1727568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T00:00:00Z","timestamp":1727568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Scholarship on how fentanyl affects the complexities of correctional settings is limited in Canada, as scholars have focused on the prevalence of opioid use and overdose in prisons, as well as community treatment and access following release. Fentanyl constitutes a continuing challenge both in prisons and broader society.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The current qualitative, interview-based empirical study examines how fentanyl is interpreted by correctional officers (COs, <jats:italic>n<\/jats:italic>\u2009=\u200999) across federal prisons in Canada, some of whom have worked in institutions with a high presence of fentanyl, while others have less exposure to the drug. We found that while many COs had responded to an overdose during their first or second year on the job, most COs who had did not perceive the event to be psychologically traumatic nor were concerned about the presence and availability fentanyl in their work environment, or they were indifferent. Yet this finding competes with the 41.4% of officers who did express concern about the presence of fentanyl \u2013 suggesting both a \u201cnormalization\u201d of fentanyl as a workplace hazard as well as an underpinning social concern.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We discuss the implications of these complicated findings in relation to reducing workplace stressors and countering misinformation that, in addition to other potential occupational factors, may be responsible for the concerns of COs tied to the presence of fentanyl.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13722-024-00504-3","type":"journal-article","created":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T08:01:30Z","timestamp":1727596890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Normalizing fentanyl: interpreting the perceived \u2018risk\u2019 of correctional officer work"],"prefix":"10.1186","volume":"19","author":[{"given":"Rosemary","family":"Ricciardelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0622-2838","authenticated-orcid":false,"given":"Matthew S.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian","family":"Foley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,29]]},"reference":[{"issue":"6","key":"504_CR1","doi-asserted-by":"publisher","first-page":"224","DOI":"10.24095\/hpcdp.38.6.02","volume":"38","author":"L Belzak","year":"2018","unstructured":"Belzak L, Halverson J. Evidence synthesis - the opioid crisis in Canada: a national perspective. Health Promotion Chronic Disease Prev Can. 2018;38(6):224\u201333. https:\/\/doi.org\/10.24095\/hpcdp.38.6.02.","journal-title":"Health Promotion Chronic Disease Prev Can"},{"issue":"11","key":"504_CR2","doi-asserted-by":"publisher","first-page":"e048944","DOI":"10.1136\/bmjopen-2021-048944","volume":"11","author":"C Bodkin","year":"2021","unstructured":"Bodkin C, Bondy S, Regenstreif L, Kiefer L, Kouyoumdjian F. Rates of opioid agonist treatment prescribing in provincial prisons in Ontario, Canada, 2015\u20132018: a repeated cross-sectional analysis. BMJ Open. 2021;11(11):e048944. https:\/\/doi.org\/10.1136\/bmjopen-2021-048944.","journal-title":"BMJ Open"},{"key":"504_CR3","doi-asserted-by":"publisher","first-page":"103131","DOI":"10.1016\/j.drugpo.2021.103131","volume":"92","author":"L McKendy","year":"2021","unstructured":"McKendy L, Biro SM, Miron M, Keown LA. Understanding overdose incidents in Canadian federal custody. Int J Drug Policy. 2021;92:103131. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103131.","journal-title":"Int J Drug Policy"},{"key":"504_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.drugalcdep.2018.09.003","volume":"193","author":"N Bozinoff","year":"2018","unstructured":"Bozinoff N, DeBeck K, Milloy M-J, Nosova E, Fairbairn N, Wood E, Hayashi K. Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada. Drug Alcohol Depend. 2018;193:42\u20137. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.09.003.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"504_CR5","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/add.15737","volume":"117","author":"M Kurz","year":"2022","unstructured":"Kurz M, Dale LM, Min JE, Hongdilokkul N, Greiner L, Olley M, McLeod KE, Slaunwhite A, Nosyk B. Opioid agonist treatment uptake within provincial correctional facilities in British Columbia. Can Addict. 2022;117(5):1353\u201362. https:\/\/doi.org\/10.1111\/add.15737.","journal-title":"Can Addict"},{"key":"504_CR6","doi-asserted-by":"publisher","unstructured":"Russell C, Nafeh F, Pang M, MacDonald SF, Derkzen D, Rehm J, Fischer B. Opioid agonist treatment in Ontario, Canada: a mixed methods study. BMC Public Health. 2022;22(1). https:\/\/doi.org\/10.1186\/s12889-022-12685-0.","DOI":"10.1186\/s12889-022-12685-0"},{"key":"504_CR7","doi-asserted-by":"publisher","first-page":"109113","DOI":"10.1016\/j.drugalcdep.2021.109113","volume":"229","author":"K McLeod","year":"2021","unstructured":"McLeod K, Buxton JA, Martin RE, Scow M, Felicella G, Slaunwhite AK. Use of community healthcare and overdose in the 30 days following release from provincial correctional facilities in British Columbia. Drug Alcohol Depend. 2021;229:109113. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109113.","journal-title":"Drug Alcohol Depend"},{"key":"504_CR8","doi-asserted-by":"publisher","first-page":"102951","DOI":"10.1016\/j.drugpo.2020.102951","volume":"86","author":"L Beletsky","year":"2020","unstructured":"Beletsky L, Seymour S, Kang S, Siegel Z, Sinha MS, Marino R, Dave A, Frefeld C. Fentanyl panic goes viral: the spread of misinformation about overdose risk from casual contact with fentanyl in mainstream and social media. Int J Drug Policy. 2020;86:102951. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102951.","journal-title":"Int J Drug Policy"},{"key":"504_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1086\/722105","volume":"51","author":"SM Bucerius","year":"2022","unstructured":"Bucerius SM, Sandberg S. Women in prisons. Crime Justice. 2022;51:137\u201386. https:\/\/doi.org\/10.1086\/722105.","journal-title":"Crime Justice"},{"issue":"2","key":"504_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1086\/709752","volume":"11","author":"F Caravaca-S\u00e1nchez","year":"2020","unstructured":"Caravaca-S\u00e1nchez F, Wolff N. Predictors of substance use among male prisoners in Spain: the role of childhood abuse and social support. J Soc Social Work Res. 2020;11(2):313\u201337. https:\/\/doi.org\/10.1086\/709752.","journal-title":"J Soc Social Work Res"},{"key":"504_CR11","doi-asserted-by":"crossref","unstructured":"Wheatley M, Weekes J, Moser A, Thibault K. Drugs and prisons. In: Wooldredge JD, Smith P, editors. The Oxford handbook of prisons and imprisonment. Oxford University Press; 2018. pp. 270\u201387.","DOI":"10.1093\/oxfordhb\/9780199948154.013.14"},{"issue":"3","key":"504_CR12","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.17269\/cjph.105.4193","volume":"105","author":"FG Kouyoumdjian","year":"2014","unstructured":"Kouyoumdjian FG, Calzavara LM, Kiefer L, Main C, Bondy SJ. Drug use prior to incarceration and associated socio-behavioural factors among males in a provincial correctional facility in Ontario, Canada. Can J Public Health. 2014;105(3):e198\u2013202. https:\/\/doi.org\/10.17269\/cjph.105.4193.","journal-title":"Can J Public Health"},{"key":"504_CR13","unstructured":"Canadian Mental Health Association. Substance use and addiction. 2023: https:\/\/ontario.cmha.ca\/addiction-and-substance-use-and-addiction\/"},{"key":"504_CR14","unstructured":"Government of Canada. Mental health and addictions. 2021: https:\/\/www.justice.gc.ca\/eng\/news-nouv\/photo\/video9.html"},{"issue":"3","key":"504_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.35502\/jcswb.103","volume":"4","author":"D Jones","year":"2019","unstructured":"Jones D, Bucerius S, Haggerty K. Voices of remanded women in Western Canada: a qualitative analysis. J Community Saf Well-Being. 2019;4(3):44\u201353. https:\/\/doi.org\/10.35502\/jcswb.103.","journal-title":"J Community Saf Well-Being"},{"issue":"12","key":"504_CR16","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/pds.3901","volume":"24","author":"B Fischer","year":"2015","unstructured":"Fischer B, Russell C, Murphy Y, Kurdyak P. Prescription opioids, abuse and public health in Canada: is fentanyl the new centre of the opioid crisis? Fentanyl in Canada. Pharmacoepidemiol Drug Saf. 2015;24(12):1334\u20136. https:\/\/doi.org\/10.1002\/pds.3901.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"504_CR17","doi-asserted-by":"publisher","first-page":"E605","DOI":"10.36076\/ppj.2015\/18\/E605","volume":"18","author":"Y Murphy","year":"2015","unstructured":"Murphy Y, Goldner EM, Fischer B. Prescription opioid use, Harms and interventions in Canada: a review update of New Developments and findings since 2010. Pain Physician. 2015;18(4):E605\u201314. https:\/\/doi.org\/10.36076\/ppj.2015\/18\/E605.","journal-title":"Pain Physician"},{"key":"504_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2017.10.020","volume":"183","author":"K Hayashi","year":"2018","unstructured":"Hayashi K, Milloy M-J, Lysyshyn M, DeBeck K, Nosova E, Wood E, Kerr T. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: a cross-sectional urine toxicology screening study. Drug Alcohol Depend. 2018;183:1\u20136. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.10.020.","journal-title":"Drug Alcohol Depend"},{"key":"504_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ypmed.2017.11.001","volume":"107","author":"B Fischer","year":"2018","unstructured":"Fischer B, Vojtila L, Rehm J. The \u2018fentanyl epidemic\u2019 in Canada \u2013 some cautionary observations focusing on opioid-related mortality. Prev Med. 2018;107:109\u201313. https:\/\/doi.org\/10.1016\/j.ypmed.2017.11.001.","journal-title":"Prev Med"},{"issue":"14","key":"504_CR20","doi-asserted-by":"publisher","first-page":"7507","DOI":"10.3390\/ijerph18147507","volume":"18","author":"W Jones","year":"2021","unstructured":"Jones W, (Angelica) Lee M-H, Kaoser R, Fischer B. Correlations between changes in Medical Opioid dispensing and contributions of fentanyl to opioid-related overdose fatalities: exploratory analyses from Canada. Int J Environ Res Public Health. 2021;18(14):7507. https:\/\/doi.org\/10.3390\/ijerph18147507.","journal-title":"Int J Environ Res Public Health"},{"key":"504_CR21","doi-asserted-by":"publisher","first-page":"102864","DOI":"10.1016\/j.drugpo.2020.102864","volume":"83","author":"S Mitra","year":"2020","unstructured":"Mitra S, Boyd J, Wood E, Grant C, Milloy M-J, DeBeck K, Kerr T, Hayashi K. Elevated prevalence of self-reported unintentional exposure to fentanyl among women who use drugs in a Canadian setting: a cross-sectional analysis. Int J Drug Policy. 2020;83:102864. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102864.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"504_CR22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/00952990.2020.1771721","volume":"46","author":"R Brar","year":"2020","unstructured":"Brar R, Grant C, DeBeck K, Milloy M-J, Fairbairn N, Wood E, Kerr T, Hayashi K. Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada. Am J Drug Alcohol Abus. 2020;46(5):625\u201331. https:\/\/doi.org\/10.1080\/00952990.2020.1771721.","journal-title":"Am J Drug Alcohol Abus"},{"issue":"4","key":"504_CR23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/0033354919857084","volume":"134","author":"S Moallef","year":"2019","unstructured":"Moallef S, Nosova E, Milloy MJ, DeBeck K, Fairbairn N, Wood E, Kerr T, Hayashi K. Knowledge of fentanyl and perceived risk of overdose among persons who use drugs in Vancouver, Canada. Public Health Rep. 2019;134(4):423\u201331. https:\/\/doi.org\/10.1177\/0033354919857084.","journal-title":"Public Health Rep"},{"issue":"2","key":"504_CR24","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1177\/1362480619841900","volume":"24","author":"B Crewe","year":"2020","unstructured":"Crewe B, levins A. The prison as a reinventive institution. Theoretical Criminol. 2020;24(2):568\u201389.","journal-title":"Theoretical Criminol"},{"issue":"1","key":"504_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/soin.12269","volume":"90","author":"G Johnston","year":"2020","unstructured":"Johnston G. The kids are all white: examining race and representation in news media coverage of opioid overdose deaths in Canada. Sociol Inq. 2020;90(1):123\u201346. https:\/\/doi.org\/10.1111\/soin.12269.","journal-title":"Sociol Inq"},{"key":"504_CR26","unstructured":"Gomes T, Murray R, Kolla G, Leece P, Bansal S, Besharah J, Cahill T, Campbell T, Fritz A, Munro C, Toner L, Watford J. Changing circumstances surrounding opioid-related deaths in Ontario during the COVID-19 pandemic. Ontario Drug Policy Research Network. 2021: https:\/\/www.publichealthontario.ca\/-\/media\/documents\/c\/2021\/changing-circumstances-surrounding-opioid-related-deaths.pdf?sc_lang=en"},{"issue":"9","key":"504_CR27","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1177\/070674370304800911","volume":"48","author":"FJ Elgar","year":"2003","unstructured":"Elgar FJ, Knight J, Worrall GJ, Sherman G. Behavioural and substance use problems in rural and urban delinquent youths. Can J Psychiatry. 2003;48(9):633\u20136. https:\/\/doi.org\/10.1177\/070674370304800911.","journal-title":"Can J Psychiatry"},{"issue":"4","key":"504_CR28","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1177\/0032885512457555","volume":"92","author":"C Plourde","year":"2012","unstructured":"Plourde C, Brochu S, Gendron A, Brunelle N. Pathways of Substance Use among Female and male inmates in Canadian Federal settings. Prison J. 2012;92(4):506\u201324. https:\/\/doi.org\/10.1177\/0032885512457555.","journal-title":"Prison J"},{"issue":"1","key":"504_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1477-7517-3-11","volume":"3","author":"E Wood","year":"2006","unstructured":"Wood E, Lim R, Kerr T. Initiation of opiate addiction in a Canadian prison: a case report. Harm Reduct J. 2006;3(1):11. https:\/\/doi.org\/10.1186\/1477-7517-3-11.","journal-title":"Harm Reduct J"},{"issue":"1","key":"504_CR30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.drugalcdep.2011.12.014","volume":"124","author":"S Johnson","year":"2012","unstructured":"Johnson S, MacDonald SF, Cheverie M, Myrick C, Fischer B. Prevalence and trends of non-medical opioid and other drug use histories among federal correctional inmates in methadone maintenance treatment in Canada. Drug Alcohol Depend. 2012;124(1):172\u20136. https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.12.014.","journal-title":"Drug Alcohol Depend"},{"key":"504_CR31","unstructured":"Kelly L, Farrell MacDonald S. Comparing lifetime substance use patterns of men and women offenders (No. 14\u201344). Correctional Service Can. 2015: https:\/\/www.csc-scc.gc.ca\/research\/005008-rb-14-44-eng.shtml"},{"key":"504_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.drugpo.2019.05.018","volume":"71","author":"SM Bucerius","year":"2019","unstructured":"Bucerius SM, Haggerty KD. Fentanyl behind bars: the implications of synthetic opiates for prisoners and correctional officers. Int J Drug Policy. 2019;71:133\u20138. https:\/\/doi.org\/10.1016\/j.drugpo.2019.05.018.","journal-title":"Int J Drug Policy"},{"key":"504_CR33","unstructured":"Bell D. 5 hospitalized after fentanyl exposure at Calgary Correctional Centre. CBC News. 2017: https:\/\/www.cbc.ca\/news\/canada\/calgary\/5-hospitalized-incident-calgary-correctional-centre-1.4293788"},{"key":"504_CR34","unstructured":"Grant M. \u2018A huge problem\u2019: correctional officers in Alberta hospitalized after exposure to fentanyl during searches. CBC News. 2017: https:\/\/www.cbc.ca\/news\/canada\/calgary\/prison-guards-alberta-overdosing-fentanyl-searches-narcan-1.4235919"},{"key":"504_CR35","doi-asserted-by":"publisher","first-page":"103303","DOI":"10.1016\/j.drugpo.2021.103303","volume":"95","author":"PR Attaway","year":"2021","unstructured":"Attaway PR, Smiley-McDonald HM, Davidson PJ. Perceived occupational risk of fentanyl exposure among law enforcement. Int J Drug Policy. 2021;95:103303. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103303.","journal-title":"Int J Drug Policy"},{"key":"504_CR36","doi-asserted-by":"publisher","unstructured":"del Pozo B, Sightes E, Kang S, Goulka J, Ray B, Beletsky LA. Can touch this: training to correct police officer beliefs about overdose from incidental contact with fentanyl. Health Justice. 2021;34. https:\/\/doi.org\/10.1186\/s40352-021-00163-5.","DOI":"10.1186\/s40352-021-00163-5"},{"key":"504_CR37","doi-asserted-by":"publisher","first-page":"103480","DOI":"10.1016\/j.drugpo.2021.103480","volume":"100","author":"S Farrell MacDonald","year":"2022","unstructured":"Farrell MacDonald S, Russell C, Beauchamp T, Derkzen D, Fischer B. Comparing characteristics and outcomes of different opioid agonist treatment modalities among opioid-dependent federal men correctional populations in Canada. Int J Drug Policy. 2022;100:103480. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103480.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"504_CR38","doi-asserted-by":"publisher","first-page":"e0192431","DOI":"10.1371\/journal.pone.0192431","volume":"13","author":"FG Kouyoumdjian","year":"2018","unstructured":"Kouyoumdjian FG, Patel A, To MJ, Kiefer L, Regenstreif L. Physician prescribing of opioid agonist treatments in provincial correctional facilities in Ontario, Canada: a survey. PLoS ONE. 2018;13(2):e0192431. https:\/\/doi.org\/10.1371\/journal.pone.0192431.","journal-title":"PLoS ONE"},{"issue":"10","key":"504_CR39","first-page":"1154","volume":"167","author":"B Sibbald","year":"2002","unstructured":"Sibbald B. Methadone maintenance expands inside federal prisons. Can Med Assoc J. 2002;167(10):1154\u20131154.","journal-title":"Can Med Assoc J"},{"key":"504_CR40","unstructured":"Cheverie M, Johnson S, Moser A. Buprenorphine Maintenance Treatment for opioid dependent inmates (B-48). Correctional Service Can. 2010: https:\/\/www.csc-scc.gc.ca\/research\/005008-b48-eng.shtml"},{"issue":"1","key":"504_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40352-022-00174-w","volume":"10","author":"L Regenstreif","year":"2022","unstructured":"Regenstreif L, Sadik M, Beaulieu E, Bodkin C, Kiefer L, Guenter D, Lee PWP, Kouyoumdjian FG. Buprenorphine\/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation. Health Justice. 2022;10(1):11. https:\/\/doi.org\/10.1186\/s40352-022-00174-w.","journal-title":"Health Justice"},{"issue":"1","key":"504_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1108\/IJPH-12-2017-0058","volume":"15","author":"LA Pearce","year":"2019","unstructured":"Pearce LA, Mathany L, Rothon D, Kuo M, Buxton JA. An evaluation of take Home Naloxone program implementation in British columbian correctional facilities. Int J Prison Health. 2019;15(1):46\u201357. https:\/\/doi.org\/10.1108\/IJPH-12-2017-0058.","journal-title":"Int J Prison Health"},{"issue":"4","key":"504_CR43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1108\/IJPH-02-2020-0012","volume":"16","author":"A Marmel","year":"2020","unstructured":"Marmel A, Bozinoff N. Punitive discontinuation of opioid agonist therapy during incarceration. Int J Prison Health. 2020;16(4):337\u201342. https:\/\/doi.org\/10.1108\/IJPH-02-2020-0012.","journal-title":"Int J Prison Health"},{"issue":"1","key":"504_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12954-021-00525-0","volume":"18","author":"C McCaughran-Contreras","year":"2021","unstructured":"McCaughran-Contreras C, Fernando S, Sikora M, Hawkins J, Kniseley M, Snyder D, Long C, Robson J, Slaunwhite A, Salmon A. Substance use and overdose risk: documenting the perspectives of formerly incarcerated persons in the Fraser East region of BC. Harm Reduct J. 2021;18(1):77. https:\/\/doi.org\/10.1186\/s12954-021-00525-0.","journal-title":"Harm Reduct J"},{"issue":"3","key":"504_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/02024458-201512000-00002","volume":"6","author":"LO Lanoie","year":"2015","unstructured":"Lanoie LO. Opioid substitution therapy in Canada\u02bcs prisons. Can J Addict. 2015;6(3):5\u20137. https:\/\/doi.org\/10.1097\/02024458-201512000-00002.","journal-title":"Can J Addict"},{"key":"504_CR46","doi-asserted-by":"publisher","first-page":"102695","DOI":"10.1016\/j.drugpo.2020.102695","volume":"78","author":"JJ Carroll","year":"2020","unstructured":"Carroll JJ, Rich JD, Green TC. The protective effect of trusted dealers against opioid overdose in the U.S. Int J Drug Policy. 2020;78:102695.","journal-title":"Int J Drug Policy"},{"issue":"11","key":"504_CR47","doi-asserted-by":"publisher","first-page":"e052739","DOI":"10.1136\/bmjopen-2021-052739","volume":"8","author":"R Ricciardelli","year":"2021","unstructured":"Ricciardelli R, et al. CCWORK protocol: a longitudinal study of Canadian correctional workers\u2019 well-being, organizations, roles and knowledge. BMJ Open. 2021;8(11):e052739. https:\/\/doi.org\/10.1136\/bmjopen-2021-052739.","journal-title":"BMJ Open"},{"key":"504_CR48","unstructured":"Charmaz K. Constructing grounded theory. Sage Publications Ltd.; 2006."},{"key":"504_CR49","doi-asserted-by":"crossref","unstructured":"Glaser BG, Strauss AL. The Discovery of grounded theory: strategies for qualitative research. Aldine Publishing Company; 1967.","DOI":"10.1097\/00006199-196807000-00014"},{"key":"504_CR50","unstructured":"Oliphant RC. Healthy minds, safe communities: supporting our public safety officers through a national strategy for operational stress injuries. Standing Comm Public Saf Natl Secur. 2016: https:\/\/www.ourcommons.ca\/documentviewer\/en\/42-1\/secu\/report-5"},{"issue":"1","key":"504_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/14624749922227711","volume":"1","author":"A Liebling","year":"1999","unstructured":"Liebling A, Price D, Elliott C. Appreciative inquiry and relationships in prison. Punishm Soc. 1999;1(1):71\u201398. https:\/\/doi.org\/10.1177\/14624749922227711.","journal-title":"Punishm Soc"},{"issue":"2","key":"504_CR52","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1177\/1525822X19838237","volume":"31","author":"MA Cascio","year":"2019","unstructured":"Cascio MA, Lee E, Vaudrin N, Freedman DA. A team-based approach to open coding: considerations for creating intercoder consensus. Field Methods. 2019;31(2):116\u201330. https:\/\/doi.org\/10.1177\/1525822X19838237.","journal-title":"Field Methods"},{"issue":"6","key":"504_CR53","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1177\/019394599902100603","volume":"21","author":"J Kendall","year":"1999","unstructured":"Kendall J. Axial coding and the grounded theory controversy. West J Nurs Res. 1999;21(6):743\u201357. https:\/\/doi.org\/10.1177\/019394599902100603.","journal-title":"West J Nurs Res"},{"key":"504_CR54","doi-asserted-by":"crossref","unstructured":"Horwitz A. What\u2019s normal? Reconciling biology and culture. Oxford University Press; 2016.","DOI":"10.1093\/acprof:oso\/9780190603243.001.0001"},{"issue":"3","key":"504_CR55","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/09687637.2015.1110565","volume":"23","author":"R Coomber","year":"2016","unstructured":"Coomber R, Moyle L, South N. The normalisation of drug supply: the social supply of drugs as the other side of the history of normalisation. Drugs: Educ Prev Policy. 2016;23(3):255\u201363. https:\/\/doi.org\/10.3109\/09687637.2015.1110565.","journal-title":"Drugs: Educ Prev Policy"},{"issue":"19","key":"504_CR56","doi-asserted-by":"publisher","first-page":"10018","DOI":"10.3390\/ijerph181910018","volume":"18","author":"K Konyk","year":"2021","unstructured":"Konyk K, et al. Assessing relative stressors and mental disorders among Canadian provincial correctional workers. Int J Environ Res Public Health. 2021;18(19):10018. https:\/\/doi.org\/10.3390\/ijerph181910018.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"504_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/23774657.2021.1978906","volume":"9","author":"MS Johnston","year":"2024","unstructured":"Johnston MS, Ricciardelli R, McKendy L. Suffering in silence: work and mental health experiences among provincial correctional workers in Canada. Corrections: Policy Pract Res. 2024;9(1):1\u201319. https:\/\/doi.org\/10.1080\/23774657.2021.1978906.","journal-title":"Corrections: Policy Pract Res"},{"issue":"7","key":"504_CR58","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1177\/00938548221081468","volume":"49","author":"MS Johnston","year":"2022","unstructured":"Johnston MS, Ricciardelli R, McKendy L. Improving the mental health of correctional workers: perspectives from the field. Criminal Justice Behav. 2022;49(7):951\u201370. https:\/\/doi.org\/10.1177\/00938548221081468.","journal-title":"Criminal Justice Behav"},{"key":"504_CR59","unstructured":"Government of Canada. Naloxone. 2022: https:\/\/www.canada.ca\/en\/health-canada\/services\/opioids\/naloxone.html?utm_campaign=hc-sc-opioid-mit-22-23&utm_medium=sem&utm_source=ggl&utm_content=ad-text-en&utm_term=naloxone&adv=2223-313900&id_campaign=18213523151&id_source=144283879641&id_content=619285594739&gclid=CjwKCAiAmuKbBhA2EiwAxQnt76FZhsHt8a4-tAzYf4C9mMaf1i9jfFydTwtP6QwUqcYmVnzpxLZtKBoCaUMQAvD_BwE&gclsrc=aw.ds#3."},{"key":"504_CR60","unstructured":"Alberta Health Services. Intramuscular and nasal Naloxone administration: suspected opioid poisoning (overdose) decision support tool. 2020: https:\/\/www.albertahealthservices.ca\/assets\/info\/hrs\/if-hrs-im-nasal-naloxone-administration-opioid-poisoning-dst.pdf"},{"key":"504_CR61","doi-asserted-by":"crossref","unstructured":"Ricciardelli R. Also serving time: Canada\u2019s provincial and territorial correctional officers. University of Toronto; 2019.","DOI":"10.3138\/9781487513115"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-024-00504-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-024-00504-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-024-00504-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T08:01:38Z","timestamp":1727596898000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-024-00504-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,29]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["504"],"URL":"https:\/\/doi.org\/10.1186\/s13722-024-00504-3","relation":{},"ISSN":["1940-0640"],"issn-type":[{"type":"electronic","value":"1940-0640"}],"subject":[],"published":{"date-parts":[[2024,9,29]]},"assertion":[{"value":"4 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research\u2019s ethics protocols received approval from the Memorial University of Newfoundland (File No. 20190481). All participants provided informed consent before participating in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}